Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ligands Targeting α9-Containing Nicotinic Acetylcholine Receptors: Structure-Activity Relationships and Therapeutic Potential in Neuropathic Pain.

Created on 12 Nov 2026

Authors

Megan J Jurek, Christian J Peters, Andrew P Riley

Published in

Journal of medicinal chemistry. Volume 69. Issue 21. Pages 24960-24974. Nov 12, 2026.

Abstract

Neuropathic pain remains a significant clinical challenge due to the varying efficacies and aversive effects associated with the currently available treatments. Most notably, the addiction potential associated with opioid use for pain presents a critical need for non-opioid-targeting analgesics. In the last two decades, α9-containing nicotinic acetylcholine receptors (nAChRs) have been evaluated preclinically for their potential as a new target for neuropathic pain therapies. In this perspective, we discuss several classes of ligands that modulate these receptors, highlighting hurdles that have arisen during their development and efforts that have been made to improve their therapeutic potential. Additionally, we consider the significant role these ligands have played in current and future drug discovery for this target.

PMID:
43018582
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement